665 related articles for article (PubMed ID: 29760127)
1.
Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
[TBL] [Abstract][Full Text] [Related]
2.
Yu X; Gao X; Li C; Luo J; Wen S; Zhang T; Ma Y; Dong L; Wang F; Huang H
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138571
[TBL] [Abstract][Full Text] [Related]
3.
Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
[TBL] [Abstract][Full Text] [Related]
4.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Susceptibility Testing Using the MYCO Test System and MIC Distribution of 8 Drugs against Clinical Isolates of Nontuberculous Mycobacteria from Shanghai.
Ying R; Yang J; Wu X; Yu F; Sha W
Microbiol Spectr; 2023 Feb; 11(2):e0254922. PubMed ID: 36802218
[TBL] [Abstract][Full Text] [Related]
6.
Zhu R; Shang Y; Chen S; Xiao H; Ren R; Wang F; Xue Y; Li L; Li Y; Chu N; Huang H
Microbiol Spectr; 2022 Dec; 10(6):e0137222. PubMed ID: 36250885
[TBL] [Abstract][Full Text] [Related]
7.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0068922. PubMed ID: 35943269
[TBL] [Abstract][Full Text] [Related]
8.
Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
[TBL] [Abstract][Full Text] [Related]
10.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
[TBL] [Abstract][Full Text] [Related]
11. [Distribution and drug resistance of nontuberculous
Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
[No Abstract] [Full Text] [Related]
12. Efficacy of PBTZ169 and pretomanid against Mycobacterium avium,
Zheng L; Qi X; Zhang W; Wang H; Fu L; Wang B; Chen X; Chen X; Lu Y
Front Cell Infect Microbiol; 2023; 13():1115530. PubMed ID: 37077530
[TBL] [Abstract][Full Text] [Related]
13. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
Ruth MM; Sangen JJN; Remmers K; Pennings LJ; Svensson E; Aarnoutse RE; Zweijpfenning SMH; Hoefsloot W; Kuipers S; Magis-Escurra C; Wertheim HFL; van Ingen J
J Antimicrob Chemother; 2019 Apr; 74(4):935-943. PubMed ID: 30649327
[TBL] [Abstract][Full Text] [Related]
14.
Sun Q; Liao X; Wang C; Jiang G; Yang J; Zhao J; Huang H; Wang G; Li H
J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708979
[No Abstract] [Full Text] [Related]
15. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
Gitti Z; Mantadakis E; Maraki S; Samonis G
Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease.
van Ingen J; Totten SE; Helstrom NK; Heifets LB; Boeree MJ; Daley CL
Antimicrob Agents Chemother; 2012 Dec; 56(12):6324-7. PubMed ID: 23027189
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases.
Huh HJ; Kim SY; Jhun BW; Shin SJ; Koh WJ
Infect Genet Evol; 2019 Aug; 72():169-182. PubMed ID: 30315892
[TBL] [Abstract][Full Text] [Related]
19. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.
Schwartz M; Fisher S; Story-Roller E; Lamichhane G; Parrish N
Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988
[TBL] [Abstract][Full Text] [Related]
20.
Schulthess B; Akdoğan Kittana FN; Hömke R; Sander P
Antimicrob Agents Chemother; 2022 May; 66(5):e0234621. PubMed ID: 35420492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
